CO

Global Cord Bloo
NYSE

Real-time Quotes | Nasdaq Last Sale

5.38
+0.02
+0.37%
After Hours: 5.50 +0.12 +2.23% 16:45 06/24 EDT
OPEN
5.45
PREV CLOSE
5.36
HIGH
5.45
LOW
5.30
VOLUME
303.39K
TURNOVER
--
52 WEEK HIGH
6.31
52 WEEK LOW
2.810
MARKET CAP
653.94M
P/E (TTM)
8.93
1D
5D
1M
3M
1Y
5Y
Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2021 Financial Results
/PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release unaudited ...
PR Newswire - PRF · 2d ago
5 Value Stocks To Watch In The Healthcare Sector
What Defines a Value Stock?
Benzinga · 05/24 13:50
48 Biggest Movers From Friday
Gainers
Benzinga · 05/24 08:55
12 Health Care Stocks Moving In Friday's Intraday Session
 
Benzinga · 05/21 16:37
30 Stocks Moving In Friday's Mid-Day Session
Gainers
Benzinga · 05/21 16:01
Overview Of Value Stocks In The Healthcare Sector
The Meaning Behind Value Stocks
Benzinga · 05/03 13:49
5 Value Stocks In The Healthcare Sector
Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likel...
Benzinga · 04/26 15:15
Global Hematopoietic Stem Cell Transplant Market to Grow with a Substantial CAGR Throughout 2021 - 2029; Increasing Research on Hematopoietic Stem Cell Transplantation to Create Numerous Opportunities for Market Growth
Apr 08, 2021 (AmericaNewsHour) -- Research Nester released a report titled "Hematopoietic Stem Cell Transplant Market: Global Demand Analysis &...
AmericaNewsHour · 04/08 12:37
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CO. Analyze the recent business situations of Global Cord Bloo through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CO stock price target is 15.00 with a high estimate of 15.00 and a low estimate of 15.00.
EPS
Institutional Holdings
Institutions: 58
Institutional Holdings: 24.38M
% Owned: 20.06%
Shares Outstanding: 121.55M
TypeInstitutionsShares
Increased
6
1.93M
New
11
1.05M
Decreased
9
674.26K
Sold Out
6
810.79K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
+0.19%
Healthcare Providers & Services
+0.43%
Key Executives
Chairman/Chief Executive Officer/Director
Ting Zheng
Chief Financial Officer/Director
Albert Chen
Corporate Executive
Rui Arashiyama
Chief Technology Officer
Xin Xu
Non-Executive Director
Ping Xu
Non-Executive Independent Director
Mark Chen
Non-Executive Independent Director
Siu Chuen Cheng
Non-Executive Independent Director
Jack Chow
Non-Executive Independent Director
Ken Lu
Non-Executive Independent Director
Jennifer Weng
Declaration Date
Dividend Per Share
Ex-Div Date
06/26/2018
Dividend USD 0.08
07/27/2018
About CO
Global Cord Blood Corporation, formerly China Cord Blood Corporation, is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. It also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The Company provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants.

Webull offers kinds of Global Cord Blood Corp stock information, including NYSE:CO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CO stock methods without spending real money on the virtual paper trading platform.